Evaluating outcomes of mother–infant pairs using dolutegravir for HIV treatment during pregnancy

OBJECTIVES: Dolutegravir (DTG), a second-generation integrase inhibitor, is an effective treatment for HIV but its safety and efficacy are not well established in pregnancy. Here, we assess maternal and infant outcomes of mother–infant pairs using DTG-containing regimens during pregnancy. METHODS: W...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:AIDS
Asıl Yazarlar: Grayhack, Clara, Sheth, Anandi, Kirby, Olivia, Davis, Jennifer, Sibliss, Kedesha, Nkwihoreze, Hervette, Aaron, Erika, Alleyne, Gregg, Laguerre, Roberta, Rana, Aadia, Badell, Martina, Momplaisir, Florence
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2018
Konular:
Clinical Science: Concise Communication
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6125741/
https://ncbi.nlm.nih.gov/pubmed/29944472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001931
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller